Global Health Innovative Technology Fund Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2016
NCT02661373
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Global Fund | Global Health Innovative Technology Fund

Active Ingredients

Drugs in Phase 2 Trials (1)

(+)-sj000557733 (2 trials)

Drugs in Other Trials (3)

artemether (1 trial)

lumefantrine (Coartem) (1 trial)

multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4